RxDoctor Payments Data

Mary White

Family · Danville, KYNPI 1366938649

Payments from drug & device makers

$2,686in general payments, 2019–2025

Across 158 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$432
  • Biohaven Pharmaceutical Holding Company Ltd.$294
  • Novo Nordisk$275
  • Pfizer$238
  • GSK$210
  • Lilly USA, LLC$181
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$2,686100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,686 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$49,894
EliquisApixaban30$44,435
JanuviaSitagliptin Phosphate23$25,911
RybelsusSemaglutide22$20,910
MounjaroTirzepatide17$17,661
JardianceEmpagliflozin18$16,604
OzempicSemaglutide16$14,994
Breo ElliptaFluticasone/Vilanterol24$14,964
TrulicityDulaglutide13$12,423
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$9,672
Metformin Er GastricMetformin Hcl11$2,292
Albuterol Sulfate HfaAlbuterol Sulfate79$2,273
Lisinopril237$1,835
Metoprolol Succinate123$1,420
Omeprazole141$1,366

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$210$64,85974 claims
PfizerEliquis$238$44,43530 claims
Novo NordiskRybelsus, Ozempic$275$35,90438 claims
Lilly USA, LLCMounjaro, Trulicity, Olanzapine$181$30,53344 claims
MerckJanuvia$15$25,91123 claims
Boehringer IngelheimJardiance$15$16,60418 claims
AbbVieSynthroid$432$74912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Danville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →